Recurrent respiratory papillomatosis (RRP) remains a challenging disease afflicting children
and adults alike, resulting in an estimated $120 million per year in United States healthcare …

Purpose To this day, there is no cure for recurrent respiratory papillomatosis (RRP). Multiple
surgical procedures are performed to achieve symptom relief and prevention of airway …

Objective Despite recent advancement recurrent respiratory papillomatosis (RRP) remains a
rare but challenging benign airway neoplasm. In recent years there has been significant …

Objectives Pulmonary papillomatosis is a rare but severe manifestation of recurrent
respiratory papillomatosis (RRP). Efficacy data of systemic bevacizumab for pulmonary RRP …

Objective The clinical course of recurrent respiratory papillomatosis (RRP) varies from
spontaneous remission to severe airway obstruction with wide variability in recurrence …

RRP is declining in incidence but remains a challenging disease to treat with great costs to
patients, families, and the healthcare system. As the disease continues to be better …

Despite advances in diagnostic and therapeutic techniques, tracheal tumors are still a
medical challenge. Although studies are still trying to find the best surgical techniques as …

Recurrent respiratory papillomatosis (RRP) consist of benign tumours along the airway
caused by human papillomavirus infection. Papillomas may cause changes in phonation …

Recurrent Respiratory Papillomatosis (RRP) is a rare but severe manifestation of human
papillomavirus (HPV). As our knowledge about HPV infections has expanded, it has become …

Objectives/Hypothesis Recurrent respiratory papillomatosis (RRP) is a rare, potentially life‐
threatening, disease that impacts the voice, breathing, and quality of life of patients …